CAMESA helps parents and doctors manage the side effects of second generation antipsychotics in children.
The Canadian Alliance for Monitoring Effectiveness and Safety of Antipsychotics in Children (CAMESA) guidelines were developed by a group of physicians, health professionals and researchers from across Canada, with the support of the Canadian Institutes of Health Research. The goal of the CAMESA guidelines is to improve the quality of life of children with mental health disorders by promoting antipsychotic drug safety.
There are three CAMESA guidelines:
- How to monitor antipsychotic drug safety
- How to manage or treat metabolic complications of antipsychotic medications if they occur (such as weight gain, or elevated cholesterol)
- How to manage or treat extrapyramidal complications of antipsychotic medications if the occur (involuntary movements)
The guidelines synthesize research findings and provide recommendations on how to perform these tasks.